Phenyl isoxazole voltage-gated sodium channel blockers: Structure and activity relationship

被引:13
|
作者
Macsari, Istvan [1 ]
Sandberg, Lars [1 ]
Besidski, Yevgeni [1 ]
Gravenfors, Ylva [1 ]
Ginman, Tobias [1 ]
Bylund, Johan [2 ]
Bueters, Tjerk [2 ]
Eriksson, Anders B. [3 ]
Lund, Per-Eric [3 ]
Venyike, Elisabet [3 ]
Arvidsson, Per I. [4 ,5 ,6 ]
机构
[1] AstraZeneca R&D, Innovat Med, CNSP iMed Sci, Med Chem, SE-15185 Sodertalje, Sweden
[2] AstraZeneca R&D, Innovat Med, CNSP iMed Sci, DMPK, SE-15185 Sodertalje, Sweden
[3] AstraZeneca R&D, Innovat Med, CNSP iMed Sci, Neurosci, SE-15185 Sodertalje, Sweden
[4] AstraZeneca R&D, Innovat Med, CNSP iMed Project Management, SE-15185 Sodertalje, Sweden
[5] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Chem, SE-75123 Uppsala, Sweden
[6] Univ KwaZulu Natal, Sch Pharm & Pharmacol, ZA-4001 Durban, South Africa
关键词
Sodium channel blockers; Na(V)1.7 blocker; Neuropathic pain; Phenyl isoxazoles; Voltage-gated channel; SCN9A; PAIN;
D O I
10.1016/j.bmcl.2011.05.041
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Blocking of certain sodium channels is considered to be an attractive mechanism to treat chronic pain conditions. Phenyl isoxazole carbamate 1 was identified as a potent and selective Na(V)1.7 blocker. Structural analogues of 1, both carbamates, ureas and amides, were proven to be useful in establishing the structure-activity relationship and improving ADME related properties. Amide 24 showed a good overall in vitro profile, that translated well to rat in vivo PK. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3871 / 3876
页数:6
相关论文
共 50 条
  • [1] Phenyl isoxazole voltage-gated sodium channel blockers: Structure and activity relationship
    Macsari, Istvan
    Sandberg, Lars
    Besidski, Yevgeni
    Gravenfors, Yiva
    Ginman, Tobias
    Bylund, Johan
    Bueters, Tjerk
    Arvidsson, Per I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [2] Voltage-Gated Sodium Channels: Structure and Function of Complexes with Sodium Channel Blockers
    Wallace, B. A.
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 10A - 10A
  • [3] Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers
    Kers, Inger
    Csjernyik, Gabor
    Macsari, Istvan
    Nylof, Martin
    Sandberg, Lars
    Skogholm, Karin
    Bueters, Tjerk
    Eriksson, Anders B.
    Oerther, Sandra
    Lund, Per-Eric
    Venyike, Elisabet
    Nystrom, Jan-Erik
    Besidski, Yevgeni
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) : 5618 - 5624
  • [4] Voltage-Gated Sodium Channel Blockers for the Treatment of Chronic Pain
    Matulenko, Mark A.
    Scanio, Marc J. C.
    Kort, Michael E.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (04) : 362 - 376
  • [5] Medicinal chemistry of neuronal voltage-gated sodium channel blockers
    Anger, T
    Madge, DJ
    Mulla, M
    Riddall, D
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (02) : 115 - 137
  • [6] The crystal structure of a voltage-gated sodium channel
    Jian Payandeh
    Todd Scheuer
    Ning Zheng
    William A. Catterall
    Nature, 2011, 475 : 353 - 358
  • [7] The crystal structure of a voltage-gated sodium channel
    Payandeh, Jian
    Scheuer, Todd
    Zheng, Ning
    Catterall, William A.
    NATURE, 2011, 475 (7356) : 353 - U104
  • [8] Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain
    Shao, Pengcheng P.
    Ye, Feng
    Weber, Ann E.
    Li, Xiaohua
    Lyons, Kathryn A.
    Parsons, William H.
    Garcia, Maria L.
    Priest, Birgit T.
    Smith, McHardy M.
    Felix, John P.
    Williams, Brande S.
    Kaczorowski, Gregory J.
    McGowan, Erin
    Abbadie, Catherine
    Martin, William J.
    McMasters, Daniel R.
    Gao, Ying-Duo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (18) : 5334 - 5338
  • [9] The voltage-gated sodium channel
    Keynes, RD
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 506P : 22S - 22S
  • [10] Discovery of voltage-gated sodium channel blockers for the treatment of neuropathic pain
    Watanabe, Shuzo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 39P - 39P